Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906758 · ClinicalTrials.gov registry record · Phase 3
Ultra-Low Contrast Angiography in AKI
A Phase 3 study of Acute Kidney Injury, sponsored by Tulane University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 2
- Study locations
NCT05906758: Recruiting Phase 3 study of Acute Kidney Injury, sponsored by Tulane University.
NCT05906758 is a Phase 3 study of Acute Kidney Injury that is actively recruiting participants, run by Tulane University. The registered enrollment target is 32 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906758, a Phase 3 study of Acute Kidney Injury, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
Primary Outcome
CIN is defined as an increase in serum creatinine by 0.5mg/dl or a relative rise of 25% from the baseline value. The investigators will measure the incidence of CIN by the increase in serum creatinine to see if the incidence will be the same in both arms whether the patient received the immediate angiography or if it was delayed until kidney function has been stabilized.
Conditions Studied
Interventions
- PROCEDURE Angiography
Study Locations (2)
Louisiana
- Tulane University Medical Center - New Orleans
- University Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-09-05 |
| Est. Completion | 2026-12 |
| Phase | Phase 3 |
What NCT05906758 shows while recruiting
NCT05906758 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Angiography is the first listed.
NCT05906758 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05906758 about?
NCT05906758 is a clinical study titled "Ultra-Low Contrast Angiography in AKI". The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
What is the current status of trial NCT05906758?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2025-09-05. Estimated completion is 2026-12.
What conditions does trial NCT05906758 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT05906758?
The interventions under investigation include: Angiography (PROCEDURE).
Who is sponsoring clinical trial NCT05906758?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906758 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05906758's enrollment target sits among peer trials
32 63rd of 74 higher than 11 of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Melatonin for Prevention of Kidney Injury
RECRUITING · Phase 3
-
SAfety of Regional Citrate Anticoagulation (SARCA Study)
RECRUITING · Phase 3
-
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
COMPLETED · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI